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A recent monograph „Lung Diseases” issued 
by the National Medical Publisher (PZWL) in 
relation with the XXIV Conference of the Polish 
Thoracic Society (Wisła, May 7−10, 2016) inc-
ludes a number of state-of-art papers addressing 
key pulmonological issues. The topic of its first 
article is asthma and chronic obstructive pul-
monary disease (COPD) [1]. The contents of this 
paper has triggered our interest and concern re-
garding epidemiological aspects of the diseases 
covered in this communication. In particular we 
paid attention to the paragraph on epidemiology 
of COPD because — to our knowledge — there 
is a need to obtain reliable estimates of the oc-
currence of this disease in the Polish population 
and this need is more apparent when confronted 
with epidemiological data on COPD available in 
many countries.
The quoted article concludes that in Poland, 
in men and women aged 40 years or more, the 
prevalence of COPD is 10%. Such an estimate pla-
ces a risk on the upper margin of a range 5−10% 
that was derived from more than 100 studies on 
COPD, performed in many countries since the 
70ties, XX century [2]. 
It is of importance that the quoted figure 
reflects — for the Polish population — the fin-
dings obtained in 526 inhabitants of the Kraków 
region who were examined more that 10 years ago 
within the Polish section of the BOLD project, and 
that the case definition was based on the GOLD 
classification (stage ≥ 2) [3]. Similar level of the 
occurrence of COPD (10.7% in subjects aged 40 
years or more) was found in an earlier study inc-
luding 676 inhabitants of Warszawa [4]. Another 
study performed in the town of Zabrze among 559 
people aged 19−69 years showed the presence 
of COPD in 13.9% of men and 7.2% of women 
[5]. Two latter projects used GOLD recommen-
dations to diagnose COPD and their results were 
published between 2002 and 2003. Other more 
recent Polish studies on COPD mostly deal with 
clinical manifestation of the disease or report on 
its occurrence among patients registered with 
family practice centers [6, 7]. One of those studies 
revealed the frequency of COPD of 12.8% among 
men and 7.1% among women, aged 40 years or 
more [10], however the figures provide a poor 
estimate of the population-based prevalence of 
COPD due to methodological circumstances. The 
currently published study, aiming at the clinical 
manifestation of asthma and COPD, included 
15973 patients registered with many family prac-
tice centers in Poland and showed that 20.0% of 
men and women had COPD, diagnosed according 
to GOLD recommendations [8]. Again, the figure 
cannot be used as a reliable estimate because 
investigation into the prevalence of COPD was 
not a goal of the study.
Results of our questionnaire survey on respi-
ratory diseases performed within GA2LEN project 
in the town of Chorzow in 2008 and including 
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2800 subjects aged 15–75 years showed that in 
the age group 40 years or more 5.2% of men and 
3.3% of women had COPD ever diagnosed by phy-
sician [Unpublished report – Department of Epi-
demiology, Medical University of Silesia]. On the 
other hand, in this age group, 12.1% of men and 
12.9% of women had — in the past — diagnosis 
of asthmatic or spastic chronic bronchitis. In the 
age group 60 years or more 7.2% of men and 3.3% 
of women had COPD diagnosed by physician and 
13.4% of men and 15.4% of women had asthma-
tic/spastic chronic bronchitis ever diagnosed by 
physician. The survey protocol does not allow 
to infer on population-based magnitude of the 
problem but the findings are in line with a view 
on underdiagnosis of COPD in many countries, 
in Poland even reaching 80% [7, 9]. 
A need for better evidence on epidemiology, 
etiopathogenesis and clinical aspects of COPD in 
the countries of Eastern Europe is clearly recom-
mended in a European Lung White Book [2]. Such 
studies are necessary to adress not only epidemio-
logical questions but also other important points, 
such as phenotypes of COPD and contributions 
from the field of biomarkers, modern molecular 
and genetic tools or novel imaging techniques [2]. 
The obvious need to obtain reliable estima-
tes concerning prevalence and phenotypes of 
COPD in Poland can be only met by a full-scale 
epidemiological project implemented according 
to a good epidemiology practice. Such studies 
in adults are difficult and the crucial points 
are representativeness of the study groups and 
participation rate, at least at the first stage of the 
project [10]. The data briefly reviewed in our 
communication prove a need for preparation and 
implementation of a large nation-wide study on 
COPD in Poland, involving perhaps a cross-sec-
tional assessement in the first phase and a cohort 
approach as its continuation. Such a study would 
serve a number of goals, from scientific assess-
ment of the problem to much needed enforcement 
of scientific activities of the whole respiratory 
society and to promotion of its role and visibility 
on the international scene.
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